Home Blood Disorders

Blood Disorders

Latest
(Left two panels) Hepatocyte-like cells (HLCs) differentiated from the stem cells of patients with hemophilia B show very low levels of clotting factor IX
Blood Disorders

CRISPR “One Shot” Cell Therapy for Hemophilia Developed

Scientists say CRISPR could be used to exploit naturally occurring mutations as treatments for blood diseases such as beta-thalassemia and sickle cell disease. [Creative Commons EM Unit
Blood Disorders

CRISPR Use Could Lead to “Organic” Gene Therapies for Blood Disorders

Daiichi Sankyo U.S. headquarters in Basking Ridge
Blood Disorders

Daiichi Sankyo Eliminates 280 U.S. Jobs

Blood Disorders

Redosable Gene-Therapy Developer Generation Bio Wins $100M Series B Financing

Blood Disorders

Oxford BioMedica, Bioverativ to Develop Lentiviral Vectors for Hemophilia Gene Therapy

Blood Disorders

FDA Imposes Clinical Hold on Bellicum Lead Candidate BPX-501

Blood Disorders

Sanofi Snaps Up Bioverativ for $11.6B, Boosting Hemophilia and Rare Disease...

Source: End-Stage Renal Disease Network Program
Blood Disorders

Automated Artificial Intelligence Speeds Identification of Blood Pathogens

Blood Disorders

PhaseBio Inks License to Develop MedImmune’s Reversal Agent for Blood Thinner

Blood Disorders

Novartis to Develop Treatments for Eye, Blood Disorders Using Homology’s AAV...

Load more

Recently Featured

Stay Connected

558,087FansLike
45,566FollowersFollow
Copyright © 2018 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up